| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |